Alupent Overdose

It is possible to take too much Alupent. Overdose symptoms may include seizures, an irregular heart rhythm, and insomnia. Some of the more serious symptoms of an Alupent overdose could even include cardiac arrest or loss of life. Treatment for an Alupent overdose usually involves supportive care, which can include administering fluids through an intravenous line or using medications that can reverse the effects of Alupent.

An Overview of Alupent Overdose

Alupent® (metaproterenol sulfate) is a prescription medication used to treat asthma and other similar lung problems. The effects of an Alupent overdose will vary depending on a number of factors, including how much Alupent was taken and whether it was taken with any other medicines, alcohol, street drugs, or a combination of these.
 
If you happen to overdose on Alupent, seek medical attention immediately.
 

Symptoms of an Alupent Overdose

Alupent overdose symptoms may include:
 
  • Chest pain (angina)
  • High blood pressure (hypertension) or low blood pressure (hypotension)
  • A fast heart rate (tachycardia)
  • Nervousness
  • Headaches
  • Shakiness (tremors)
  • Dry mouth
  • Feelings of a rapidly or forcefully beating heart (heart palpitations)
  • Nausea
  • Dizziness
  • Insomnia
  • Seizures
  • An irregular heart rhythm (arrhythmia)
  • Fatigue
  • Low potassium in the blood (hypokalemia)
  • Cardiac arrest
  • Loss of life.
     

Treatment for an Alupent Overdose

Treatment for an Alupent overdose involves supportive care. This type of care consists of treating the symptoms that occur as a result of the overdose. For example, supportive treatment options may include:
 
  • Fluids through an intravenous line (IV)
  • Medications (such as beta blockers) to reverse the effects of Alupent
  • Other treatments based on the complications that occur.
     
It is important that you seek medical attention immediately if you believe that you may have overdosed on Alupent.
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation